| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 3 | — | — | — | 7 | — | — | — | — | 3 | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡ |
|
| 2026 | 2.86 |
—
—
—
|
| 2025 | 2.67 |
—
—
—
—
|
| 2024 | 2.48 |
—
—
—
—
|
| 2023 | 2.32 |
—
—
—
—
|
| 2022 | 2.16 |
—
—
—
—
|
| 2021 | 2.01 |
—
—
—
—
|
| 2020 | 1.89 |
—
—
—
—
|
| 2019 | 1.85 |
—
—
—
—
|
| 2018 | 1.78 |
—
—
—
—
|
| 2017 | 1.71 |
—
—
—
—
|
| 2016 | 1.65 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 6,587.00 | 5,578.00 | 7,435.00 | 8,305.00 |
| Receivables | 10,838.00 | 10,976.00 | 14,701.00 | 13,942.00 |
| Inventory | 11,777.00 | 12,768.00 | 13,364.00 | 14,409.00 |
| Other | 19,215.00 | 21,811.00 | 24,832.00 | 27,256.00 |
| 48,417.00 | 51,133.00 | 60,332.00 | 63,912.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 10,698.00 | 12,897.00 | 15,895.00 | 16,998.00 |
| ST’ Debt | 1,472.00 | 2,535.00 | 3,616.00 | 5,525.00 |
| Other | 17,183.00 | 18,616.00 | 21,615.00 | 22,671.00 |
| 46,761.00 | 51,499.00 | 58,784.00 | 63,245.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 22,076.00 | 24,708.00 | — | — |
—
|
| ’25 | 20,306.00 | 21,581.00 | 22,478.00 | 24,238.00 |
88,603.00
|
| ’24 | 19,305.00 | 19,721.00 | 20,089.00 | 21,623.00 |
80,738.00
|
| ’23 | 17,214.00 | 18,315.00 | 13,464.00 | 19,927.00 |
68,920.00
|
| ’22 | 15,716.00 | 16,314.00 | 16,951.00 | 18,093.00 |
67,074.00
|
| ’21 | 15,251.00 | 15,880.00 | 16,213.00 | 17,044.00 |
64,388.00
|
| ’20 | 11,360.00 | 14,061.00 | 14,747.00 | 16,419.00 |
56,587.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,855.00 | 3,547.00 | — | — |
—
|
| ’25 | 1,305.00 | 458.00 | 4,639.00 | 4,165.00 |
10,567.00
|
| ’24 | 342.00 | 2,733.00 | 2,523.00 | 1,561.00 |
7,159.00
|
| ’23 | (863.00) | 719.00 | 3,316.00 | 4,711.00 |
7,883.00
|
| ’22 | 476.00 | 1,286.00 | 778.00 | 4,628.00 |
7,168.00
|
| ’21 | 723.00 | 1,326.00 | 1,932.00 | 3,161.00 |
7,142.00
|
| ’20 | 1,132.00 | 210.00 | 1,622.00 | 1,370.00 |
4,334.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,211.00 | 2,820.00 | — | — |
—
|
| ’25 | 688.00 | (194.00) | 3,904.00 | 3,050.00 |
7,448.00
|
| ’24 | (288.00) | 2,041.00 | 1,842.00 | 328.00 |
3,923.00
|
| ’23 | (1,537.00) | 33.00 | 2,530.00 | 3,691.00 |
4,717.00
|
| ’22 | (45.00) | 704.00 | 130.00 | 3,604.00 |
4,393.00
|
| ’21 | 304.00 | 938.00 | 1,421.00 | 2,037.00 |
4,700.00
|
| ’20 | 729.00 | (276.00) | 1,203.00 | 571.00 |
2,227.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.51 | 1.57 | — | — |
—
|
| ’25 | 1.14 | 1.22 | 1.41 | 1.19 |
4.96
|
| ’24 | 1.28 | 0.08 | 1.09 | 1.10 |
3.55
|
| ’23 | 0.97 | 0.90 | (0.68) | 1.05 |
2.23
|
| ’22 | 0.72 | 0.88 | 0.94 | 0.96 |
3.50
|
| ’21 | 0.50 | 0.68 | 0.93 | 0.46 |
2.56
|
| ’20 | (0.10) | (2.55) | 0.17 | 0.09 |
(2.59)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 80.27 | 68.56 | 83.96 | 112.27 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 106.02 | 104.91 | 128.70 | 188.00 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 182,000 | 185,000 | 186,000 | 180,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.37 | 0.37 | 0.43 | 0.49 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 67,074.00 | 68,920.00 | 80,738.00 | 88,603.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.38% | 17.54% | 19.09% | 20.08% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,117.00 | 3,836.00 | 6,194.00 | 8,733.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.12% | 5.57% | 7.67% | 9.86% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,327.00 | 3,380.00 | 5,013.00 | 7,069.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,108.00 | 4,211.00 | 4,364.00 | 4,378.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.46 | 48.33 | 60.61 | 66.05 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 3.52 | 2.24 | 3.58 | 5.02 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.86 | 5.53 | 5.37 | 7.88 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.88) | (2.22) | (2.43) | (2.33) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 2.98 | 3.31 | 2.95 | 5.55 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 50.27 | 43.06 | 46.49 | 50.02 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,475.50 | 1,426.00 | 1,332.10 | 1,341.40 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 28.64 | 37.71 | 32.32 | 36.46 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.22 | 1.76 | 1.91 | 2.78 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.01 | 1.98 | 2.49 | 3.67 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.60 | 2.30 | 2.35 | 3.12 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.71 | 33.66 | 48.39 | 37.12 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,168.00 | 7,883.00 | 7,159.00 | 10,567.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2,775.00) | (3,166.00) | (3,236.00) | (3,119.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,393.00 | 4,717.00 | 3,923.00 | 7,448.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,329.00 | 1,656.00 | (366.00) | 1,548.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31,914.00 | 43,827.00 | 41,261.00 | 37,904.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25,694.00 | 37,240.00 | 35,683.00 | 30,469.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74,178.00 | 61,410.00 | 61,923.00 | 67,102.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.25% | 1.99% | 2.94% | 4.03% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.44% | 2.26% | 4.19% | 5.96% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.98% | 4.71% | 7.74% | 10.44% | — | — | — |
ROE
|
RTX Corporation shines as a powerhouse in aerospace and defense, perfectly primed to ride surging global demand fueled by geopolitical tensions, NATO rearmament, and commercial air travel’s roaring comeback. Born from the 2020 merger of United Technologies and Raytheon, RTX has streamlined via spin-offs, boasting a massive $200B+ backlog from hits like Patriot missiles, F-35 components, and hypersonic tech. Revenue has exploded at a 41% CAGR since 2016 to $80.7B in 2024 (17% YoY surge), with projections rocketing to $105.6B by 2028—powered by U.S. defense budgets topping $850B and lean ops lifting revenue per employee 72%.
Profitability is rebounding like a phoenix: net income flipped from a 2020 loss to $5B in 2024, with EPS set to more than double to $7.19 by 2028 amid gross margins climbing to 20%+ and FCF/share jumping to $5.55 next year. Free cash flow soared 89% YoY to $7.4B, funding buybacks and dividends while ROE doubles to 10.4%. Stock action mirrors this strength, with analyst targets signaling 14% upside (high end 19%), trading at attractive growth multiples versus peers.
Insider sells into strength are routine, not red flags, as macro tailwinds like Ukraine aid and China risks supercharge the backlog. RTX isn’t just resilient—it’s a disruptive compounder eyeing AI autonomy and eVTOL plays. Dive into the full analysis for the charts, catalysts, and blockbuster return math that make this a must-own for growth seekers!
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.